Posted on February 22nd, 2010 by Beth Backus
NEW YORK, Feb. 17 /PRNewswire-USNewswire/ — The Michael J. Fox Foundation for Parkinson's Research today announced $3.5 million in total funding to nine research studies aiming to advance understanding of the LRRK2 gene, a promising therapeutic target for Parkinson's disease. Using a multipronged approach that includes collaboration between the research teams, the funded projects will help accelerate LRRK2 therapeutic development efforts.
Tags: Mayo Clinic Jacksonville
You must be logged-in to the site to post a comment.